Literature DB >> 1313897

Nucleotide 880 splice donor site required for efficient transformation and RNA accumulation by human papillomavirus type 16 E7 gene.

N S Belaguli1, M M Pater, A Pater.   

Abstract

Mutations within coding sequences of the various human papillomavirus type 16 (HPV-16) genes have been used to demonstrate that the HPV-16 E7 gene is necessary and sufficient for transformation of rodent cells. We now provide evidence that, in addition to E7 coding sequences, a small cis-acting region immediately flanking the 3' end of E7 coding sequences is also required for transformation. This was shown by translation termination linker insertion, progressive deletion analysis, and site-directed mutagenesis. Disruption of the nucleotide (nt) 880 splice donor site within the 3'-flanking region by deletion of as few as 4 nt or substitution of 3 nt totally abolished transformation. Regeneration of the wild-type sequence in a previously transformation-incompetent splice site mutant restored transformation. Mutating the wild-type splice donor site to the consensus splice site resulted in a stronger transformation phenotype, while mutating the +2 position of the consensus sequence significantly reduced the frequency of transformation. It was shown with RNase protection assays that the amount of E7 mRNA in transformation-deficient splice site mutants was much lower. Nuclear runoff experiments revealed that there was no change in the rate of synthesis of E7 message in the nt 880 splice site mutant. Furthermore, mutations of HPV-16 sequences indicated that the two other early region splice donor sites have no more than minor roles in transformation and efficient RNA accumulation. These results indicate that the specific integrity of the nt 880 splice donor site is essential for both accumulation of E7 RNA and efficient E7-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313897      PMCID: PMC241027     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  In vitro polyadenylation is stimulated by the presence of an upstream intron.

Authors:  M Niwa; S D Rose; S M Berget
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

2.  Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16.

Authors:  M Rohlfs; S Winkenbach; S Meyer; T Rupp; M Dürst
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

3.  Mechanism for cryptic splice site activation during pre-mRNA splicing.

Authors:  K K Nelson; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project.

Authors:  P Senapathy; M B Shapiro; N L Harris
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

6.  Identification of a transforming gene of human papillomavirus type 16.

Authors:  A Tanaka; T Noda; H Yajima; M Hatanaka; Y Ito
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line.

Authors:  J Doorbar; A Parton; K Hartley; L Banks; T Crook; M Stanley; L Crawford
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

8.  A point mutational analysis of human papillomavirus type 16 E7 protein.

Authors:  C Edmonds; K H Vousden
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  3 in total

1.  Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.

Authors:  Monika Somberg; Stefan Schwartz
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions.

Authors:  R Mittal; A Pater; M M Pater
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

3.  Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.

Authors:  Xiaoze Li; Cecilia Johansson; Carlos Cardoso Palacios; Anki Mossberg; Soniya Dhanjal; Monika Bergvall; Stefan Schwartz
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.